Feifei Xu

Feifei Xu

Auto-generated profile, based on publicly available information

Feifei Xu

School of Pharmacy, Nanjing Medical University, Nanjing, 211166, China

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2014 in Stem Cells
Verified
Journal Article
Open access
PDF file
WZWeiwei Zheng
Weiwei Zheng
XDXiao-Ming Dong
Xiao-Ming Dong
RYRong-Hua Yin
Rong-Hua Yin
FXFei-Fei Xu
Fei-Fei Xu
HNHong-Mei Ning
Hong-Mei Ning
XYXiao-Ming Yang
Xiao-Ming Yang
Erythroid differentiation‐associated gene (EDAG) has been considered to be a transcriptional regulator that controls hematopoietic cell differentiation, proliferation, and apoptosis. The role of EDAG in erythroid differentiation of primary erythroid progenitor cells and in vivo remains unknown. In this study, we found that EDAG is highly expressed in CMPs and MEPs and upregulated during the erythroid differentiation of CD34+ cells following erythropoietin (EPO) treatment. Overexpression of EDAG induced erythroid differentiation of CD34+ cells in vitro and in vivo using immunodeficient mice. Conversely, EDAG knockdown reduced erythroid differentiation in EPO‐treated CD34+ cells. Detailed mechanistic analysis suggested that EDAG forms complex with GATA1 and p300 and increases GATA1 acetylation and transcriptional activity by facilitating the interaction between GATA1 and p300. EDAG deletion mutants lacking the binding domain with GATA1 or p300 failed to enhance erythroid differentiation, suggesting that EDAG regulates erythroid differentiation partly through forming EDAG/GATA1/p300 complex. In the presence of the specific inhibitor of p300 acetyltransferase activity, C646, EDAG was unable to accelerate erythroid differentiation, indicating an involvement of p300 acetyltransferase activity in EDAG‐induced erythroid differentiation. ChIP‐PCR experiments confirmed that GATA1 and EDAG co‐occupy GATA1‐targeted genes in primary erythroid cells and in vivo. ChIP‐seq was further performed to examine the global occupancy of EDAG during erythroid differentiation and a total of 7,133 enrichment peaks corresponding to 3,847 genes were identified. Merging EDAG ChIP‐Seq and GATA1 ChIP‐Seq datasets revealed that 782 genes overlapped. Microarray analysis suggested that EDAG knockdown selectively inhibits GATA1‐activated target genes. These data provide novel insights into EDAG in regulation of erythroid differentiation. Stem Cells 2014;32:2278–2289

7 February 2024 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
YYYongbing Yang
Yongbing Yang
YWYanan Wang
Yanan Wang
ZWZhongcheng Wang
Zhongcheng Wang
HYHuanyu Yan
Huanyu Yan
YGYi Gong
Yi Gong
SYShuo Yang
Shuo Yang

5 February 2015 in Chinese Medical Journal
Verified
Journal Article
Open access
FXFei-Fei Xu
Fei-Fei Xu
XLXiuhua Liu
Xiuhua Liu
Calreticulin (CRT) is major Ca 2+ -binding chaperone mainly resident in the endoplasmic reticulum (ER) lumen. Recently, it has been shown that non-ER CRT regulates a wide array of cellular responses. We previously found that CRT was up-regulated during hypoxia/reoxygenation (H/R) and this study was aimed to investigate whether CRT nuclear translocation aggravates ER stress (ERS)-associated apoptosis during H/R injury in neonatal rat cardiomyocytes. Apoptosis rate and lactate dehydrogenase (LDH) leakage in culture medium were measured as indices of cell injury. Immunofluorescence staining showed the morphological changes of ER and intracellular translocation of CRT. Western blotting or reverse transcription polymerase chain reaction was used to detect the expression of target molecules. Compared with control, H/R increased apoptosis rate and LDH activity. The ER became condensed and bubbled, and CRT translocated to the nucleus. Western blotting showed up-regulation of CRT, Nrf2, activating transcription factor 4 (ATF4), CHOP and caspase-12 expression after H/R. Exogenous CRT overexpression induced by plasmid transfection before H/R increased cell apoptosis, LDH leakage, ER disorder, CRT nuclear translocation and the expression of ERS-associated molecules. However, administration of the ERS inhibitor, taurine, or CRT siRNA alleviated cell injury, ER disorder, and inhibited ERS-associated apoptosis. Our results indicated that during H/R stress, CRT translocation increases cell apoptosis and LDH leakage, aggravates ER disorder, up-regulates expression of nuclear transcription factors, Nrf2 and ATF4, and activates ERS-associated apoptosis.

13 March 2023 in Talanta
Verified
Journal Article
Closed access
ZWZhongcheng Wang
Zhongcheng Wang
LLLi Li
Li Li
YKYuqiong Kuang
Yuqiong Kuang
JYJiang Yao
Jiang Yao
FXFeifei Xu
Feifei Xu
C.Chen Yun .
Chen Yun .

1 February 2019 in Clinica Chimica Acta
Verified
Journal Article
Closed access
TYTing Yang
Ting Yang
PXPengfei Xu
Pengfei Xu
LGLize Gu
Lize Gu
ZXZhiyuan Xu
Zhiyuan Xu
WGWeihong Ge
Weihong Ge
FXFeifei Xu
Feifei Xu

21 April 2026 in Renal Failure
Verified
Journal Article
Open access
YQYali Qian
Yali Qian
ZJZheng Jiang
Zheng Jiang
HMHongjun Miao
Hongjun Miao
LCLili Chu
Lili Chu
JZJingxia Zeng
Jingxia Zeng
XGXuhua Ge
Xuhua Ge
Sepsis-induced acute kidney injury (S-AKI) is a common and serious complication in critically ill children with a poor prognosis, and its early and accurate prediction remains challenging due to the lack of reliable biomarkers. Urinary small-molecule metabolomics offers a promising approach to capture the dynamic metabolic changes during the progression of S-AKI. In this two-center prospective observational study, we enrolled 360 children from both centers. Urine samples were collected within 24h after hospitalized children diagnosed with sepsis, stored at -80 °C, and analyzed using gas chromatography-mass spectrometry (GC-MS). Based on urinary metabolic fingerprints (U-MF), we developed and validated a machine learning model for early prediction of S-AKI. The Shapley Additive Explanations (SHAP) algorithm was applied to visually explain the optimal model. A panel of 10 metabolites was selected as common discriminative features. Among the 4 machine learning models evaluated, the support vector machine (SVM) demonstrated the best performance in both the discovery cohort (AUC 0.94, 95% CI: 0.91-0.98) and the external validation cohort (AUC 0.89, 95% CI: 0.82-0.96), enabling early prediction of S-AKI within 24 h. Furthermore, the U-MF panel was integrated into an open-access online platform to facilitate clinical translation. Our findings suggest that U-MF combined with machine learning holds promise as a robust and noninvasive approach with potential utility for early prediction of S-AKI in pediatric patients.